Background: The aim of the present study was to see the prevalence of allergic comorbidities among the country's population and to increase impression of cost savings in the management of allergic comorbidities. 
Introduction :
Asthma and allergies, including allergic rhinoconjunctivitis and atopic dermatitis, are common throughout the world with a high burden of morbidity and cost. Most patients with asthma also have rhinitis. 1 suggesting the concept of 'one airway, one disease'; a good fraction of patients with allergic rhinitis presents clinically demonstrable asthma even though a greater number has nonspecific nonspecific bronchial hyper reactivity 2, 3 supporting the term of 'ARIA' document. The global health problem allergic rhinitis is increasing in prevalence [4] [5] [6] .
However, in many instances, symptomes predominate in one organ and may be hidden in the other although they exist and truly, the common inflammatory process with the interconnected mechanisms well affect the upper and lower airways [7] [8] [9] [10] . Environmental factors are mostly thought to be responsible for the world wide increase in allergic rhinitis and atopic asthma 11 but there is undoubtedly a genetic component in allergic rhinitis as in other other allergic diseases [12] [13] [14] [15] [16] [17] [18] . Allergic rhinitis it self is a common risk factor for atopic asthma since the risk of asthma among the patients with allergic rhinitis was up to 300 times than among the patients without rhinitis 2 ; however, in case of severe asthma the role of rhinosinusitis should be carefully excluded hence it begets additional risk of asthma development. Allergic rhinitis induces nonspecific bronchial hyper reactivity exerting a unique physiological behaviour separating asthmactis and normal subjects. The presence of peripheral eosinophilia in patients with rhinosinusits indicates a high likelihood of extensive allerigc diseases-number of eosinophil increased in nasal membrane and blood 24 hours after bronchial exposure [19] [20] [21] [22] [23] . Epithelial cells represent the first barrier of both upper and lower respiratory tract and thus are the logical common targets for a comprehensive integrated therapecutic approach [24] [25] [26] [27] [28] [29] . Association between allergies should be assessed from the socioeconomic aspect; risk of an asthma-related event for the treated group of rhinitis was about half that for untrcated group [30] [31] [32] and patients receiving intranasal corticosteroids had a reduced risk for emergency asthma department visit in comparison to those who did not receive the treatment 33 . Yearly medical charges for those with asthma and concomitant allergic rhinitis was average 46% higher than for those with asthma alone 38 . The age of onset of atopy may be an important confounding factor for the development of asthma and rhinitis or rhinitis alone---atopy acquired at an early age, before the age of 6 years, is an important predictive factor for asthma continuing into late childhood whereas atopy acquired later was only associated with seasonal allergic rhinitis 23, 27, 32, 33 .
Methods:
The study was carried out ENT out patient department of Dhaka Medical College Hospital, Dhaka, from January 2011 to January 2012 and 125 patients of clinically diagnosed allergic rhinitis with or without other allergies were selected over the period. 
Results:

Discussion:
The international study of asthma and allergies in children noted the prevalence of allergic rhinoconjvactivitis in 6-7 years old as 0.8 -14.9 percent and in 13-14 years as 1.4-39.7 percent as different countries throughout the world 5 with a significant correlation between the prevalence of asthma and rhinitis in school children. The Swiss study on Air pollution and lung diseases in adults noted the prevalence of allergic rhinitis as 13.5 percent(female 12.6 percent, male 14.3 percent) 6 . Allergic rhinitis usually happens in over 65% of patients with allergic/atopic asthma and in over 80% of patients with nonallergic asthma 1 . The Copenhagen allergy study noted that 42-52 percent patients with rhinitis had asthma and more than 99 percent of patients with atopic asthma also had allergic rhinitis 7 . Both diseases frequently co-exist in the same patients, with asthma present in 20-50% of patients with allergic rhinitis and rhinitis present in upto 80% of patients with asthmachallenging the nose with allergens will induce the influx of inflammatory cells in the lower airways and vice versa 11 . Positive family history is the best established risk factor of allergic diseases. Suggested possible environmental factors include life style changes, urbanization of non-westernized societies, increased exposure to allergens, pollutants and irritants, diminished protective nutrients, decrease in infections leading to a reduced Th 1-type immune response (the hygiene hypothesis) 13 and stress. 14 Air pollutants certainly increase symptomatic rhinitis and diesel exhaust particles may induce a Th2-like inflammation 20 ; ozone may also be a relevant factor. 21 Genes involved in allergic rhinitis and atopic asthma are located mainly on 5q chromosome, also on 11q, 13, 12q chromosome and regulate the production of concerned cytokines and chemical mediators 15 .The CD14 gene maps to chromosome 5q 31, a candidate region for loci regulating total serum lgE 36 . Well known causative agents affecting both nose and bronchi are allergens and aspirin. 16 All of the most common triggers of occupational asthma can induce occupational rhinitis and vice versa-asthma is more pronounced with low molecular weight agents whereas rhinitis with high molecular weight agents and this highlights the importance of ceasation of allergen exposure in allergic rhinitis in order to prevent asthma 2 . Rhinitis is a risk factor for the development of subsequent asthma and is a frequent cause of asthma exacerbations and there is evidence that rhinitis treatment reduces asthma. 17 Onset of asthma was associated with allergic rhinitis -rhinitis increased the risk of asthma by about three times among both atopic and nonatopic patients and by more than five times among patients with higher IgE titre. 34, 35 Presence of diagnosed allergic rhinitis in infancy was associated with a doubling of the risk of developing atopic asthma by11 years of age 18 whereas in adults, 10.5 percent of students diagnosed with allergic rhinitis went to develop asthma compared with 3.6%of those who did not have rhinitis 19 . Early life smoking in mothers or smoking during pregnancy is strongly associated with an incrcase in the prevalence of atopic sensitization, rhinitis and asthma. However, nasal mucosa is more exposed to noxious environment than the bronchial mucosa but epithelial shedding is more pronounced in the bronchi 22 . In patients with moderate to severe asthma, eosinophilic inflammation is more pronounced in bronchi than in the nose whereas in patients with mild asthma, the inflammation is similar in both sites; moreover, the inflammation in the nose exists in asthmatics with or without nasal symptoms. Central to the pathogenesis of rhinitis and asthma is the role of eosinophil and airway epithelium-after release of and differentiation of progenitor cells, eosinophil, basophil, mast cells are typically recruited to the inflammation tissue in atopic individuals, thus is the enhanced expression of IL-5 in the nasal epithelium 24 hours after bronchial challenge and increased eosinophil in bronchial mucosa after nasal challenge. When exposed to water, pollen allergens are exposed into submicronic particles, the starch granules, which can reach the lower airway and induce asthma. A recent study shows that endobronchial allergen challenge induced nasal and bronchial symptoms along with reduction in pulmonary and nasal functions. 24 Nasal viral infection both in children and adults exacerbates asthma ------------rhinoviruses are the major cause and a trigger of acute asthma exacerbation. Diagnosis of allergic rhinitis is aided by thorough history taking including presenting respiratory symptomes, symptomes of co-morbidity, family history, occupational, environmental, dietary and drug use history, history of any nonallergic triggers -frequency, severity, duration, persistence, intermittence or seasonality of symptomes, quality of life, tratment expenditure should be quaried; a full ENT examination, chest examination with pulmonary function measurement ( peak flow, spirometry), search for atopic conjunctivitis and dermatitis; estimation of specific IgE level, total IgE level for complicated allergic rhinitis since 50% patients have normal IgE level in complicated cases 25 -other test like skin prick fest, normal allergen challenge test may be required. Treatment strategies should involve both upper and lower since the latter is also affected usually and a strategy of combining treatment of both airway diseases appears to be optimum in teams of both efficacy and safety 1 . The 2 nd generation antihistamines are appropriate for the treatment of atopy and amongst them cetirizine, desloratadine, loratadine, lovocetirizine, fexofenadine are appropriate having both antihistamine and anti-inflammatory effects; They apperer to be more effective if used regularly rather than intermittently 26 and they may reduce allergic progression in children 27 and use of levocetirizine and desloratadine in asthma has been recently reviewed specially 37 . The combination of oral antinistamine and decongestants was found more effective on asthma symptomes 28 . Anti-leukotriens are helpful for mild to moderate asthma and seasonal allergic rhinitis may be an alternative to or a combination with antihistamines but they got many hazardous side effects. Topical glucocorticoides are the most effective drugs for atopic asthma and rhinitis intranasal glucocorticoides for allergic rhinitis was found to improve asthma 29, 30 Intranasal corticoids reduce the relative risk of asthma exacerbation/ hospitalization by 50% or more if combined with antihistamine 33 Beclomethasone, Triamcinolone. Momentasone are licensed from the age of six years, Fluticasone propionate from four, Fluticasone furoate from two and sodium cromoglycate is reserved for the younger age. Ketotifen, also azelastine and olopatadine, got the membrane stabilizing effect (mast cell, basoplil) as well as antihistamine effect. Oral steroides are the most effective treatment for allergic rhinitis and asthma but longterm use is contraindicated and are reserved only for complicated cases. In contrast to pharmacotherapy, immunetherapy offers more potential longterm modification and prophylaxis, and is reserved for only severe case of rhinitis and asthma and three years treatment for seasonal rhinitis in children resulted into tow or three fold reduction in risk of developing asthma 31 . Rhinitis increases the cost of asthma yearly medical charges for those with asthma and concomittant rhinitis were average 46% higher than for those with asthma alone. 38 
Conclusion :
Socioeconomic impact of allergic rhinitis should be assessed keeping the other associated conditions viz. asthma, dermatitis, sinusitis, otitis media, pharyngitis, sleep disorders, LRTI etc. in mind. Patients with both asthma and allergic rhinitis experience more physical limitations than patients with allergic rhinitis alone whose number is too low as well as rhinitis increases the costs of asthma. The epithelial-mesenchymal trophic unit exists from nose tow bronchiolar-alveolar junction and same inflammatory cells present thorought the airway suggests a continum of diseases. Rhinitis and asthma are linked by epidemiological and pathophysiological characteristics and by a common therapeutical approach. Wheather allergic rhinitis preceds asthma, triggers asthma or precipitates asthma are intuitive aspects that require supportive data.
